Aggregated price index with volume information
- Drugstore Chains stocks up 2.8% on average while median return up 1.9% in a day
- Drugstore Chains stocks up 0.8% on average while median return up 1.3% in a week
- Drugstore Chains stocks down 12.0% on average while median return down 9.7% in a month
- When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.
Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.
- 1M winners are : Winners for past month are $CVS 4.5%, $YI 1.6%
- 1M losers are : Losers for past month are $WBA -13.1%, $BIMI -40.3%
- 1W winners are : Winners for past week are $YI 5.8%, $WBA 5.3%
- 1W losers are : Losers for past week are $CVS -1.9%, $PETS -6.6%
Index correlation analysis
Correlation for the past month is 10.9%, for the past 3 months is 13.7%
In the past month for a 5 days rolling window, the highest corrrelation is 33.4%, the lowest correlation is -16.3%, the latest correlation is 33.4%
When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.
Among pairwise correlation, the highest correlation is 38.6% between BIMI and PETS
The lowest correlation is -18.2% between CVS and YI
Walgreens Boots Alliance (WBA) shares are trading higher on a Bloomberg report that the pharmacy retailer is considering former Cigna executive Tim Wentworth for CEO. Walgreens announced the surprising departure of CEO Rosalind Brewer earlier this month. Analysts at Raymond James upgraded Trimble (TRMBL) shares to "outperform" after the company announced it was selling $2 billion worth of tech assets to AGCO (AGCO). AGCO CEO Eric Hanostia told Yahoo Finance Live that the deal will help build its...
The Dow Jones reversed sharply lower after trying to reclaim its 200-day line. The 10-year yield and U.S. dollar pared early losses.
Walgreens Boots Alliance stock rose 5.7%, putting it on pace for its largest percent increase since Nov. 11, 2022 when it gained 7.2%, according to Dow Jones Market Data. It was also a leading performer in the S&P 500 in afternoon trading.
Amgen was the best-performing stock in both the Dow Jones Industrial Average and Nasdaq 100 in the third quarter, while Zions Bancorp, up 32%, was the top stock in the S&P 500.
Understanding the Risks and Rewards of Investing in Walgreens Boots Alliance
NVIDIA, e.l.f. Beauty, Walt Disney, Walgreens Boots Alliance and Cintas are part of the Zacks Market Edge blog.
Growth stock and Big Cap 20 Cencora is approaching an all time high and a buy point. A long-term partnership with Walgreens is a tailwind.
Walgreens Boots Alliance (NASDAQ: WBA) has been delivering ugly results to its shareholders for years. There's no dip here -- investors who buy the stock are trying to catch a falling knife. The consensus analyst price target for Walgreens is $35.69.
U.S. equity markets have rebounded after a challenging 2022, with the Dow Jones Industrial Average having risen by 4.4% after dropping by 8.8% in 2022. Walgreens Boots Alliance (NASDAQ: WBA), Nike (NYSE: NKE), and 3M (NYSE: MMM) have lost about 43%, 22%, and 19%, respectively, since the start of 2023. Walgreens' troubles don't just extend to this year, which is reflected in the stock performance.
Walgreens Boots Alliance (WBA) closed the most recent trading day at $21.02, moving -0.52% from the previous trading session.